SMS Lifesciences India

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue91.2667.8475.1468.1771.87
Expenses85.8466.5573.7863.4066.79
EBITDA8.714.815.719.809.67
EBIT6.685.043.187.257.11
Profit Before Tax5.423.631.364.785.07
Net Profit4.012.470.703.123.31
Financial Ratios
Operating Profit Margin9.60%10.92%7.66%14.46%13.56%
Net Profit Margin4.42%2.41%0.94%4.60%4.65%
Earning Per Share (Diluted)13.268.172.3210.3110.96
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ